Histamine-releasing factors and inhibitory factors

Int Arch Allergy Appl Immunol. 1991;94(1-4):141-3. doi: 10.1159/000235346.

Abstract

Peripheral-blood mononuclear cells (MNC) synthesize several histamine-releasing factors (HRF) spontaneously and when stimulated. Some of the characterized cytokines have histamine-releasing activity, especially connective tissue activating peptide III, neutrophil-activating peptide 2 and interleukin-3 (IL-3). At least two species of HRF remain to be characterized. MNC also secrete a histamine release-inhibitory factor (HRIF), which is a highly specific inhibitor, because it antagonizes only HRF. IL-8 resembles the low-molecular-weight species of HRIF in terms of size and specificity.

MeSH terms

  • Basophils / drug effects
  • Basophils / metabolism
  • Biomarkers, Tumor*
  • Histamine Release / drug effects*
  • Humans
  • Interleukin-8 / pharmacology
  • Leukocytes, Mononuclear / metabolism
  • Lymphokines / analysis*
  • Lymphokines / antagonists & inhibitors
  • Tumor Protein, Translationally-Controlled 1

Substances

  • Biomarkers, Tumor
  • Interleukin-8
  • Lymphokines
  • Tumor Protein, Translationally-Controlled 1